In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria.
AUTOR(ES)
Debbia, E
RESUMO
The antibacterial activity of LY146032 alone and in combination with other drugs was assayed against gram-positive isolates. Synergism was found when LY146032 was combined with netilmicin, amikacin, imipenem, and fosfomycin by both checkerboard and time-kill tests. Indifference predominated when LY146032 was combined with teicoplanin, vancomycin, and rifampin. Under no circumstances and with no combinations was an antagonistic effect detected.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172154Documentos Relacionados
- In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteria.
- In vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteria.
- In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria.
- In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
- Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032.
